Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization. (2020)
Attributed to:
Physiological resilience: mechanisms and consequences
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/ana.25880
PubMed Identifier: 32841444
Publication URI: http://europepmc.org/abstract/MED/32841444
Type: Journal Article/Review
Volume: 88
Parent Publication: Annals of neurology
Issue: 5
ISSN: 0364-5134